These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4843720)

  • 1. Effect of estrogen therapy on climacteric symptoms and tissue changes.
    Punnonen R; Rauramo L
    Acta Obstet Gynecol Scand; 1974; 53(3):267-9. PubMed ID: 4843720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
    Döring GK
    Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal adaptation in the climacteric and the question of hormone therapy in postmenopause].
    Kyank H
    Z Alternsforsch; 1966 Dec; 19(3):305-16. PubMed ID: 4294394
    [No Abstract]   [Full Text] [Related]  

  • 10. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M; Reuther G; Minne HW; Schneider HP
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women.
    Erkkola R; Lammintausta R; Punnonen R; Rauramo L
    Maturitas; 1978 Jun; 1(1):9-14. PubMed ID: 755955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Oestrogens as a cause of endometrial carcinoma.
    Br Med J; 1976 Apr; 1(6013):791-2. PubMed ID: 1260334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When applied to facial skin, does estrogen ointment have systemic effects?
    Kainz C; Gitsch G; Stani J; Breitenecker G; Binder M; Schmidt JB
    Arch Gynecol Obstet; 1993; 253(2):71-4. PubMed ID: 8215610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestriol succinate in the treatment of climacteric women (a double-blind trial).
    Järvinen PA; Kokkonen J; Ryhänen P
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:26. PubMed ID: 4941231
    [No Abstract]   [Full Text] [Related]  

  • 16. Skinfold thickness and long-term post-menopausal hormone therapy.
    Punnonen R; Vilska S; Rauramo L
    Maturitas; 1984 Apr; 5(4):259-62. PubMed ID: 6738372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kliogest--the possibility of hormonal substitution in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of castration and peroral estrogen therapy on the skin.
    Punnonen R
    Acta Obstet Gynecol Scand Suppl; 1972; 21():3-44. PubMed ID: 4511789
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
    Meaidi A; Goukasian I; Lidegaard O
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine and ovarian estrogen receptor levels in climacteric women.
    Punnonen R; Kouvonen I; Lövgren T; Rauramo L
    Acta Obstet Gynecol Scand; 1979; 58(4):389-91. PubMed ID: 525273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.